Here is a breakdown of five recalls reported by Becker’s Hospital Review in the last three months:
1. Recalled drugs: Valsartan and Valsartan/Hydrochlorothiazide
Reason for recall: A probable human carcinogen, n-nitrosodimethylamine , was found in the products
Date of recall: July 13
Drugmakers: Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals
2. Recalled drugs: Various lots of: Zofran ODT, Entresto, Azithromycin tablets, Donepezil ODT, Haloperidol, Imipramine HCl, Isosorbide Dinitrate, Naratriptan tablets, Ondansetron ODT, Ondansetron tablets, Perphenazine, Risperidone ODT
Reason for recall: Packaging does not meet federal childproofing standards
Date of recall: July 6
Drugmakers: Novartis and Sandoz
3. Recalled drug: Naloxone
Reason for recall: Embedded or loose particulate matter on the syringe plunger
Date of recall: June 4
Drugmaker: Hospira
4. Recalled drug: Taytulla birth control sample packs
Reason for recall: Placebo pills and active capsules were placed in the wrong order
Date of recall: May 29
Drugmaker: Allergan
5. Recalled product: Jaundice Meter JM-103 and Jaundice Meter JM-105
Reason for recall: Newborn injuries after users misinterpreted the device’s display
Date of recall: May 21
Devicemaker: Draeger Medical Systems
More articles on pharmacy:
Packaging concerns force Novartis, Sandoz to recall 12 drugs
Pfizer stock value dips after Trump’s tweet
8 lesser-known facts about Pfizer
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
